share_log

Paradigm Biopharmaceuticals Ltd: Type D Response Submitted and Received by the US FDA

Apr 19 06:36
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.